Renal Mass and Localized Renal Cancer (2021): Difference between revisions
Urology4all (talk | contribs) |
Urology4all (talk | contribs) |
||
| Line 106: | Line 106: | ||
******# '''Multifocal disease''' | ******# '''Multifocal disease''' | ||
******# '''Severe CKD''' | ******# '''Severe CKD''' | ||
*'''<span style="color:#ff0000">Radical nephrectomy</span>''' | *'''<span style="color:#ff0000">Radical nephrectomy</span>''' | ||
** '''<span style="color:#ff0000">Indication (1)</span>''' (when intervention is necessary for solid or Bosniak 3/4 complex cystic renal mass): | ** '''<span style="color:#ff0000">Indication (1)</span>''' (when intervention is necessary for solid or Bosniak 3/4 complex cystic renal mass): | ||
| Line 162: | Line 160: | ||
**** In this setting, renal mass biopsy (if the mass is predominantly solid) is encouraged for additional risk stratification. | **** In this setting, renal mass biopsy (if the mass is predominantly solid) is encouraged for additional risk stratification. | ||
**** If the patient continues to prefer AS, close clinical and cross-sectional imaging surveillance with periodic reassessment and counseling should be recommended. | **** If the patient continues to prefer AS, close clinical and cross-sectional imaging surveillance with periodic reassessment and counseling should be recommended. | ||
***'''<span style="color:#ff0000">In patients with familial RCC syndromes, tumors can be observed if <3 cm as the risk of metastases remains low in this setting</span>''' | |||
**** '''<span style="color:#ff0000">HLRCC and succinate dehydrogenase deficiency RCC are the exception as tumors in these syndromes are often very aggressive.</span>''' | |||
* In patients undergoing AS | * In patients undergoing AS | ||
** Periodic clinical surveillance and/or imaging is recommended in asymptomatic patients | ** Periodic clinical surveillance and/or imaging is recommended in asymptomatic patients | ||